Advertisement
Advertisement

ORIC

ORIC logo

Oric Pharmaceuticals, Inc. Common Stock

13.50
USD
Sponsored
+0.57
+4.41%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

12.38

-1.12
-8.33%

Oric Pharmaceuticals, Inc. Common Stock Profile

About

ORIC Pharmaceuticals Inc. is a clinical stage oncology company. It is focused on developing treatments which address mechanisms of therapeutic resistance. The company's product candidate consists of ORIC-101 and ORIC-533 which are in clinical stage. ORIC Pharmaceuticals Inc. is based in San Francisco, United States.

Info & Links

CEO

Jacob M. Chacko

Headquarters

240 E. GRAND AVE., 2ND FLOOR
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.oricpharma.com

Auditor

KPMG LLP

Share holders

23

Employees

104

Oric Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.28B

Enterprise Value

1.25B

Enterprise Value/EBITDA(ttm)

-8.02

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.67

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-35.35%

Return on Invested Capital(ttm)

-35.43%

Return on Assets(ttm)

-33.39%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-155.37M

Net Income Available to Common(ttm)

-140.35M

Diluted EPS(ttm)

-1.35

Share Statistics

Beta (5Y Monthly)

1.02

52-Week Change

40.19%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

103.65M

Dividend Yield

0.00%

Float4

97.75M

% Held by Insiders

5.70%

% Held by Institutions

95.05%

Balance Sheet

Total Cash(mrq)

264.76M

Total Cash Per Share(mrq)

2.55

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

13.19%

Quick Ratio(mrq)

16.33%

Book Value Per Share(mrq)

3.68

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.59

Free Cash Flow(ytd)

-64.40M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement